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osting by EAbstract Background: The ﬁeld of interventional cardiology continues to rapidly evolve as a
result of many advances in devices as well as adjunctive medications which have been paralleled
by a concomitant improvement in the safety and efﬁcacy of PCI.
Objectives: We aimed at registering our elective PCI procedures with respect to their procedure
details, outcome, in hospital complications and long term follow up. We tried to determine our
performance in comparison to other registries and to ﬁnd out risk factors associated with poor out-
come.
Patient and methods: The material of this study included 1897 patients (1564 males and 333
females) who underwent PCI at the Critical Care Department, Cairo University between January
2003 to December 2007 with a follow up of 1–5 years. Retrospective analysis of those data had been
done including clinical events such as death, MI, target vessel revascularization (TVR) and major
adverse cardiac events (MACE).
Results: The cohort was predominantly male (82.2%) with a mean age of 55 ± 9 years. We had
wide variety of PCI procedures, BMS stenting shared up 75.1% of our patients, DES 9.8%, PTCA
4.1%, failed PCI 4.4%, combined stents 1.2% and stenting with PTCA contributed 5.4% of them (A. El Nagger).
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170 A. El Nagger et al.total patients. During hospital study clinical success was achieved in 92.8% of cases with low rate of
clinical events; mortality (0.3%), MI (0.5%) with no reported cases of TVR. Angiographic success
was achieved in 95.5% of treated segments with 6.7% angiographic complications. During follow
up, death, MI, TVR and MACE rates increased from (3.2%, 2.1%, 8.5% and 10.2%) at ﬁrst year to
(24.2%, 17.2%, 35.9% and 57.2%), respectively, after 5 years follow up duration. There was a sig-
niﬁcant relationship between renal impairment, chronic total occlusion (CTO), bifurcation lesion,
long lesion (>20 mm), number of stents implanted and occurence of PCI complications.
Conclusion: Our experience is comparable to other registries. We differed in our demographic fea-
tures which affected our patient’s characteristics. However, we need to establish our own registries
based on our real life scenarios in the developing countries.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Large-scale multicenter data collection efforts have been used
to evaluate cardiovascular procedures.1–4 This work has been
limited somewhat either geographically or by institutional
selection. Furthermore, the data elements collected and their
deﬁnitions have varied.
The American College of Cardiology (ACC) established the
National Cardiovascular Data Registry (ACC-NCDR) to pro-
vide a uniform and geographically comprehensive view of car-
diovascular procedures across the Untied State of America. A
total of 139 hospitals submitted data on 100, 292 procedures
and were included in their analysis set.5,6
The Melbourne Interventional Group (MIG) also is a
voluntary collaboration of interventional cardiologists, at
eight hospitals (seven public and one private) in Australia
(Victoria region). Members of the group contributed data on
consecutive patients (undergoing PCI between April 2004 to
August 2007), to a central registry. The aim of their study
was to analyze demographic, clinical and procedural charac-
teristics of their PCI population and to report on 30-day and
12-month clinical outcomes in eligible patients.7
The European Society of Cardiology (ESC) has adopted
the Euro Heart Survey program, to evaluate to which extent
clinical practice endorses existing guidelines as well as to
identify differences in population proﬁles, patient manage-
ment, and outcome across Europe. The survey on coronary
revascularization was conducted between November 2001
and March 2002 with 1 year follow up. They reported 4770
patients with median follow up period of 12 months
(11–13 months).8
The NCVD is an initiative under the Malaysian Ministry of
Health (MOH) that collects information about cardiovascular
disease. A total of 2349 PCI cases in 1249 patients was enrolled
in the ﬁrst 6 months of 2007. The NCVD database was estab-
lished to integrate these various databases and other data
sources to achieve a nation-wide database.9
National PCI registry was held in Thailand (NR-Th) to
determine safety and efﬁcacy of PCI in Thailand. It began
on May 2006 and it recruited 4146 PCI procedures which were
performed in 27 participating sites.10
The aim of this study was to analyze demographic, clinical
and procedural characteristics of our PCI population and to
report on in hospital complications and clinical outcome with
5 years follow up. We also aimed to benchmark our registry
with other national PCI registries which would facilitate future
research and development.2. Material and methods
The Egyptian Critical Care Department Angioplasty Registry
(ECDAR) is a single-center PCI registry, where admitted pa-
tients for PCI were included in the database. The standardized
data abstraction form and dataset deﬁnitions were designed in
the light of the Cardiology Audit and Registration Data Stan-
dards (CARDS) project. The case report forms (CRFs) were
designed to collect detailed demographic, past medical history,
clinical and procedural information.
Patients who underwent elective PCI at Critical Care
Department, Cairo University Hospitals, were enrolled. Data
recording was designed for PCI procedures through the period,
from 1st January 2003 till 31st December 2007.
We examined 1897 consecutive PCI procedures between
January 2003 and December 2007. We reported demographic,
clinical and procedural characteristics of the total PCI popula-
tion enrolled during this period and clinical outcomes for in-
hospital stay and every 12-month follow up.
The interventional strategy and stent selection were left to
the discretion of the operator in all procedures. Total stent
length was used as a surrogate measure for target lesion length,
and stent diameter for target vessel diameter.
In hospital complications were recorded at the time of hos-
pital discharge. All cardiac events were documented, including
death, myocardial infarction (MI), target vessel revasculariza-
tion (TVR), and composite major adverse cardiac events
(MACE), comprising death, MI and TVR.
Ethical approval for our study was obtained from the Cairo
University Hospitals Research Ethics Committee (ERC).
Continuous variables were summarized as means and SDs.
Categorical data were summarized as percentages. Univariate
and multivariate analysis models were used to test for the pref-
erential effect of all important variable(s) on occurrence of
complications. All statistical calculations were done using
computer programs Microsoft Excel 2007 (Microsoft Corpora-
tion, NY, USA) and SPSS (Statistical Package for Social
Science).3. Results
3.1. Baseline patients characteristics
As shown in Table 1, our study is a non-controlled retrospec-
tive study involving 1897 patients who were subjected to
elective PCI in the Critical Care Department during the period
Table 1 Baseline characteristics of patients in our registry.
Patients demographics
Number 1897
Female sex 17.6%
Age (years) 55 ± 9
Risk factors
Diabetes 37.4%
Hypertension 52.9%
Smoking 74.8%
Dyslipidemia 31.3%
Family history 12.6%
Indications for PCI
STEMI 24%
UA 61.4%
St. angina 13.7%
NSTEMI 0.9%
Associated medical conditions
CHF 3.80%
Renal impairment 1.10%
Peripheral vascular disease 0.90%
CVS 0.40%
STEMI, ST elevation myocardial infarction; UA, unstable angina;
St. angina, stable angina; NSTEMI, non-ST-segment myocardial
infarction; CHF, congestive heart failure; CVS, cerbrovascular
stroke.
Table 2 Angiographic data.
Number of vessels
Single vessel 62.4%
Two vessel 30.3%
Multi-vessel 7.1%
Previous interventions
Previous stenting 162 (8.5%)
Post CABG 55 (2.9%)
Vessels
LAD 57.3%
LCX 19.4%
RCA 22.1%
LM 1.2%
ACC/AHA lesion morphology
Type A 24.8%
Type B 42.2%
Type C 33%
Lesion diameters
length (mm) 16 ± 5
% Stenosis 86 ± 40%
LAD, left anterior descending; LCX, left circumﬂex; RCA, right
coronary artery; LM, left main.
Table 3 PCI procedures and complications’ data.
PCI procedures
BMS 1425 (75.1%)
DES 186 (9.8%)
PTCA 78 (4.1%)
BMS and DES 21 (1.2%)
Stenting and PTCA 103 (5.4%)
Failed PCI 84 (4.4%)
Stent length (mm) 21 ± 5
Stent diameter (mm) 3 ± 0.25
Angiogrpahic success 95.5%
Procedure complications
Acute stent occlusion 2.2%
Branch occlusion 2.5%
Dissection 1.1%
Embolization 0.9%
Clinical success 94.2%
In hospital complications
Death 0.3%
MI 0.5%
TVR 0%
MACE 0.5%
BMS, bar metal stent; DES, drug eluting stent; TVR, target vessel
revascularization; MACE, major adverse cardiac event.
A retrospective single center registry 171from 2003 to 2007. It included 1564 males (82.4%) and 333
females (17.6%) with a mean age of 54.7 ± 9.4 years. Age
group (40–60 years old) constituted 68.8%, patients younger
than 40 years constituted 8.7% and patients older than
60 years old constituted 22.5% of all patients.
Smoking was the most common risk factor (74.8%) and
37.4% of our patients were diabetic.
Over viewing our PCI indication, unstable angina was the
most common indication (61.4%) while NSTEMI was the least
common indication to undergo PCI (1%). Sixty-seven patients
(3.8%) had manifestations of congestive heart failure with low
EF, 20 (1.1%) patients had an identiﬁed renal impairment, 16
(0.9%) patients had peripheral vascular disease and seven
(0.4%) patients had previous cerebrovascular event.
3.2. Angiographic data
As shown in Table 2, the prevalence of single vessel disease was
present in 1183 patients (62.4%), two vessels disease was evi-
dent in 575 patients (30.3%) and multi-vessel disease (MVD)
was noticed in 139 patients (7.1%). It was noted that 162
patients (8.5%) had previous coronary stenting within 2 years
after their ﬁrst PCI and 55 patients (2.9%) were considered
post CABG status.
There were 2831 vessels with 3172 affected segments with
more than 50% stenosis according to Syntax score. Not all
lesions were subjected to PCI trial. Untreated segments were
either of small caliber or located in the distal vessels. LAD
has the highest frequency (57.3%), RCA involvement was seen
in 22.1%, while LCX involvement was present in 19.4% of our
patients and left main was present in 1.2% of cases.
The most intervened segment was proximal LAD (36.8%)
followed by Mid LAD (18.2%) and proximal RCA (15%).Upon revising treated lesions, average lesion length was
16 ± 5 mm (range from 6 to 36 mm) and average stenosis
percentage before PCI was 86 ± 10%. Type B was the most
prevalent ACC/AHA morphology pattern (42.2%).
3.3. PCI procedures and complications data
As shown in Table 3, BMS stenting was done in 75.1%, DES
in 9.8% and PTCA in 4.1% of our patients, 21 patients (1.2%)
had both BMS and DES and 103 patients (5.4%) had both
Figure 3 TVR rate through the follow up period of the study.
Figure 4 MACE rate through the follow up period of the study.
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in 95.5% and failed PCI was reported in 4.4% which might
be attributed in 69% of cases due to failure of crossing by
the guide wire. About 84.7% of treated vessels were exclusively
stented with average stent length of 21 ± 5 mm and stent
diameter of 3 ± 0.25 mm.
The procedural complications including the acute stent
occlusion occurred in 2.2% of cases, side branch occlusion
was noticed in 2.5% of patients, distal embolization in 0.9%
and coronary dissection in 1.1% of patients.
3.4. Clinical success of PCI procedure: Table 3
Clinical success was achieved in 94.2% of cases. It was deﬁned
as accomplishing PCI procedure with no in hospital MACE, a
major bleeding, new or worsening renal impairment or cere-
brovascular event. In hospital death event was reported in
0.3% in our series and MI in 0.5% with no TVR event was re-
ported in our series.
3.5. Follow up data
In our registry, 1362 patients could be followed up (71.8%).
Average follow up was 2.5 ± 1.3 years (range 1–5 years). Fol-
low up was done on phone basis (71.3%) and through clinical
follow up (28.7%). MACE rate differed signiﬁcantly among
stent and PTCA groups (23.3% in stent group vs. 43.1% in
PTCA group <0.003). Death rate was 3.2% of ﬁrst year and
increased up to 24.2% after 5 years (Fig. 1). MI rate was
2.1% at 1 year increased up to 17.2% at 5 years follow up
(Fig. 2). TVR was recorded in 8% at 1 year, increased up to
35.9% at 5 years follow up (Fig. 3). MACE was 10.1% at
1 year and reached 57.2% at 5 years follow up (Fig. 4).Figure 1 Death rate through the follow up period of the study.
Figure 2 MI rate through the follow up period of the study.3.6. Risk factors for poor outcome
As shown in Table 4, there was a signiﬁcant relationship be-
tween renal impairment, complete total occlusion (CTO),
lesion length >20 mm and bifurcation lesions and occurrence
of PCI complications (25% vs. 6.6%, P< 0.002; 9.7% vs. 6%,Table 4 Risk factors and incidence of procedural
complications.
Risk factors Present/absent (+)/() % Of complications
Renal
impairment
(+ve) 25%
(ve) 6.6%
P value 0.002
CTO (+ve) 9.7%
(ve) 6%
P value 0.01
Lesion length
>20 mm
(+ve) 12%
(ve) 5.1%
P value 0.002
Bifurcation
lesion
(+ve) 14.4%
(ve) 6.3%
P value 0.01
Post-dilatation (+ve) 2.4%
(ve) 7.8%
P value 0.002
Number of
stents
1 stent 5.9%
2 stents 7.1%
3 stents 28%
P value 0.003
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P< 0.01, respectively). Post dilatation was done in 329 pa-
tients (17.3%) and has been associated with less complications’
rates (2.4% vs. 7.8%, P< 0.002), respectively. In addition,
increasing the number of deployed stents was associated with
higher incidence of complications (5.9% for stent, 7.1% for
2 stents and 28% for 3 stents).4. Discussion
PCI registries are able to longitudinally track patient outcomes
in relation to baseline patient characteristics, indications for
intervention, coronary anatomy and procedural technique.
PCI registries could detect trends towards adverse outcomes
and variations in PCI use that may warrant re-assessment of
its use in speciﬁc circumstances and facilitate monitoring and
benchmarking of PCI performance.11
PCI registries varied in their patient populations, regarding
age, sex and other associated medical conditions. Also PCI
indications varied among different PCI registries. Our registry
included signiﬁcantly smaller number of patients, with the
exception of NCVD (P value <0.001). Our patients were also
younger (55 ± 9 years) in comparison to these registries, ex-
cept for NCVD where their patients were an average age of
56 years old.6–10
Gender composition was signiﬁcantly different in our regis-
try than in other registries. Females represented 17.8% of our
total population, which was close to females’ contribution in
NCVD registry (18% of their enrolled patients). Females in
our registry were less than in other registries where females
represented 25–34% of their patient’s populations (P value
<0.001).6–10
Smoking was the most common risk factor for IHD in our
registry (74.8% of our patients). It has signiﬁcantly lower prev-
alence than in other studies (P value<0.001).6–10 Also 37.4%of
our patients were diabetic, this was higher than inACC-NCDR,
MIGandESC registries (P value<0.001). Diabetes was present
at a higher prevalence in NCVD registry (P value <0.003). Our
registry and Thailand registry had close diabetes prevalence
(37.4% vs. 37.7%). Diabetes prevalence varied among devel-
oped and developing countries. In developed countries, diabetes
ranged between 23% and 36% while in developing countries;
diabetes ranged between 37% and 43%.6–10
Unstable angina was the most prominent indication in our
study to undergo PCI (61.4%), which was close to ACC-
NCDR (62%). Unstable angina was more in our registry than
that in MIG and MCVD (14.9–26.3%) P value <0.001.6–10
In our study previous cardiac intervention was lower in our
registry in general, where it was 8.3% for previous PCI proce-
dures and 2.8% for CABG surgeries which was less than that
reported in other registries (29–35%), P value <0.001. This
difference is attributed for availability of medical care facilities
and medical awareness.6–10
Congestive heart failure manifestations were present in
3.8%, similar to MIG results.6,7 Renal functions impairment
was present to a lesser extent in our study (1.1%) while it ran-
ged from 3.6% to 6.7% in other studies (P value <0.001).6–10
Cerebrovascular disorders were present in 0.4% of patients
in our registry. This was much less than that reported in MIG
and ESC registries (5.6–6%, P< 0.001). Peripheral vascular
disease (PVD) was present in 0.9% in our study and also itwas present much less in our registry, compared to MIG,
ESC and ACC-NCDR registries (6.7–12.1%; P< 0.001).6–8
The low prevalence of renal impairment, CHF and PVD in
our registry could be attributed to the lower age of our
patients.
The extent of complex coronary artery disease in our pa-
tients is less than in other studies, P value <0.001). Single ves-
sel disease accounted for 62.4% in our study, while it
accounted for 35.2–45% in other studies. Our study had less
MVD prevalence (7.1%) in comparison to other registries
where MVD accounted for 21–58.1% in other studies. Also,
number of vessels to be treated differed between our study
and other studies.6–10
For ACC/AHA lesion morphology classiﬁcation, our
patients had simpler lesions than in other registries.7,8
Stenting was performed in 90.9% of patients enrolled in our
study while it was performed much less in ACC-NCDR and
ESC registries (71–75%, Pvalue <0.001). We had PTCA done
in 4.4% of cases, while PTCA contributed to 19% in ACC-
NCDR registry and in 11.8% in Thailand registry, P value
<0.001.6–10
Angiographic success was achieved in 95.5% in our series.
This was also echoed in other registries. Failed PCI constituted
4.4% of our PCI procedures which was comparable to that
encountered in ACC-NCDR registry (4.4% vs. 5.5%).6 Clini-
cal success was achieved in 94.2% in our series which was close
to that achieved in ACC-NCDR registry (92.2%) and higher
than that achieved in the Thailand registry (94.2% vs.
90.1%). Our results are close to results of other registries, con-
cerning procedural complications. Our in hospital MACE or
follow up MACE were less reported than in other regis-
tries.6–10
In our registry, 1362 patients were followed up (71.8%).
Average follow up time was 2.5 ± 1.3 years (range 1–5 years).
Our lower incidence of follow up MACE may be attributed to
lower age of our patients with less complex CAD anatomy.
Besides, our registry was based on elective PCI procedures,
while other registries were based on elective and urgent inter-
vention, e.g., primary PCI procedures with higher complica-
tions’ rates.6–10
Through reviewing our patients’ database, we could con-
ﬁrm a signiﬁcant relationship between renal impairment and
occurrence of PCI procedure complications. This ﬁnding was
conﬁrmed by other authors and considered a risk factor for
PCI morbidity and renal impairment has been incriminated
in risk estimation model.12–14
We tried to determine other risk factors associated with
poor outcome in our study group. Chronic total occlusion
(CTO), long lesions, i.e., >20 mm and bifurcational lesions
were signiﬁcantly related to poor outcomes in our patients.
In patients with CTO lesions, complication rate was 9.7%
vs. those with non-CTO who had a complication rate of 6%
(P value: 0.018). In another study chronic total occlusions
are known to carry worse prognosis as compared to non-
CTO lesion.15
Through reviewing our angiographic data, patients with le-
sion length >20 mm had a complications’ rate of 12%. The
length has been incorporated in angiographic determinants
of adverse outcomes after PCI.16
Patients with bifurcational lesions had a higher complica-
tions’ rate than those with non bifurcational lesions (14.4%
vs. 6.3%, P value <0.011). This was supported by many
174 A. El Nagger et al.studies that showed higher incidence of complications with
bifurcation lesion.17
Post dilatation had been associated with less complication
rates (2.4% vs. 7.8%, P value <0.002). Many authors con-
ﬁrmed such ﬁndings.18 Regarding the number of stents and
incidence of complication it was found that three stents have
been associated with a higher complications’ rate than one
or two stents and mutli-vessel PCI poses more challenge to
angiographies and increases the burden of PCI outcomes.19
We analyzed also our follow up data and concluded that
certain risk factors are related to the incidence of MACE.
Stenting vs. PTCA and Syntax score are related to MACE
occurrence in our series. Stenting had signiﬁcantly less MACE
rate than PTCA (25% vs. 44.2%, P value <0.016). This was
conﬁrmed through many studies.20 Patients with low Syntax
scores has signiﬁcantly less MACE rates than patients with
intermediate or high Syntax scores (20.2% vs. 90.4%, P value
<0.001). Syntax score has been incorporated in choice of
revascularization strategies.21
5. Conclusion
Through reviewing and comparing our data, we concluded
that our experience is comparable to other registries. We dif-
fered in our demographic features which affected our patient’s
characteristics. These ﬁndings were echoed in other developing
countries like Malaysia and Thailand.
This conﬁrmed our need to establish our own registries,
based on our real life scenarios in developing countries where
patients’ demographics differ signiﬁcantly, despite close results
which might not be true on larger scale studies.
However, despite the signiﬁcant difference in patients’ char-
acteristics (e.g. age, sex and risk factors for CAD) and com-
plexity of our lesions, our results were quite close to results
of other registries in short and long term follow up aspects
(procedural complications and our follow up MACE).
This study sheds different light from a different perspective
on the practice of cardiovascular intervention. Percutaneous
coronary intervention procedure differs from one country to
another regarding patient selection, elective vs. emergent pro-
cedures, availability of medical care facilities, medical aware-
ness, ﬁnancial restriction and operators’ preference in
selecting treatment strategies. This may lead to different results
reﬂecting the special nature of each registry.
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